Clinical Trial Update: Evaluation of the Safety of Relaxin in Preeclampsia [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety of relaxin in pre-eclampsia has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pre-eclampsia

Drugs mentioned

• Relaxin (Relaxin)

Snippet

Sponsor: Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies | Conditions: Pre-Eclampsia | Phase 1 | Status: SUSPENDED